
Kernal is creating mRNA 2.0 therapies that work in specific cells
screenshot pendingKernal Biologics is an onco-selective mRNA therapeutics company based in Cambridge, MA. The company focuses on developing innovative therapies that utilize advanced mRNA technology to program cells directly within the body, thereby enhancing the treatment options for serious illnesses such as cancer and autoimmune diseases. Their platform aims to deliver targeted sequences to specific tissues and cells, ensuring precise targeting and selective translation, which is fundamental to their approach in overcoming the limitations of current cell therapies.
The core of Kernal Biologics' technology i…